Clinical Trial Update: Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial assessed an anti-IFNγ monoclonal antibody in children with primary haemophagocytic lymphohistiocytosis; the study is completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophagocytic Lymphohistiocytosis

Drugs mentioned

• anti-IFNγ monoclonal antibody

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Primary Haemophagocytic Lymphohistiocytosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-09-04